Covid-19 roundup: AstraZeneca builds $261M deal with US CDMO player for bulk Covid-19 vaccine supply; Corporate insiders reeling in over $1B+
Less than 2 months after BARDA spearheaded US efforts to ensure a large supply of vaccine to fight Covid-19 with a $628 million alliance with …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
